Marta Schirripa

机构：Azienda Sanitaria Locale Viterbo, Ospedale di Belcolle · ORCID：0000-0001-8316-4411

发表论文 315 篇 · 总被引 4266 次 · h-index 34

代表论文

• Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population (2024 · European Journal of Cancer · 被引 54)
• Durvalumab in Advanced Biliary Tract Cancer: Real‐World Data From a Large Cohort of Patients Across Multiple International Centers (2025 · Liver International · 被引 13)
• A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC ‐D Index (2025 · Liver International · 被引 11)
• Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population (2024 · The Oncologist · 被引 10)
• Survival Outcomes with Regorafenib and/or Trifluridine/Tipiracil Sequencing to Rechallenge with Third-Line Regimens in Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Subgroup Comparison from the ReTrITA Study (2024 · Current Oncology · 被引 6)
• Longitudinal Assessment of FT3 to FT4 Conversion Ratio in Predicting the Efficacy of First-Line Pembrolizumab-Based Therapy in Advanced Non-Small Cell Lung Cancer: A Propensity-Score Matching Analysis of Data from the National Drug Monitoring Agency (2024 · Current Oncology · 被引 6)